These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 647679)

  • 41. Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene.
    Hecht SS; LaVoie EJ; Bedenko V; Pingaro L; Katayama S; Hoffmann D; Sardella DJ; Boger E; Lehr RE
    Cancer Res; 1981 Nov; 41(11 Pt 1):4341-5. PubMed ID: 7306963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn mice.
    Chang RL; Levin W; Wood AW; Yagi H; Tada M; Vyas KP; Jerina DM; Conney AH
    Cancer Res; 1983 Jan; 43(1):192-6. PubMed ID: 6847768
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of the skin tumor initiating activity of 3-methylcholanthrene and 3,11-dimethylcholanthrene in mice.
    Slaga TJ; Gleason GL; Hardin L
    Cancer Lett; 1979 Jul; 7(2-3):97-102. PubMed ID: 476615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis.
    Verma AK; Boutwell RK
    Cancer Res; 1977 Jul; 37(7 Pt 1):2196-201. PubMed ID: 861945
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of the phorbol ester 4-O-methyl-12-O-tetradecanoylphorbol-13-acetate on mouse skin in vivo: evidence for its uselessness as a negative control compound in studies on the biological effects of phorbol ester tumor promoters.
    Fürstenberger G; Richter H; Argyris TS; Marks F
    Cancer Res; 1982 Jan; 42(1):342-8. PubMed ID: 6274513
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides.
    Slaga TJ; Huberman E; Selkirk JK; Harvey RG; Bracken WM
    Cancer Res; 1978 Jun; 38(6):1699-704. PubMed ID: 647680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of 3-isobutyl-1-methylxanthine and cyclic nucleotides on the biochemical processes linked to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Perchellet JP; Boutwell RK
    Cancer Res; 1981 Oct; 41(10):3927-35. PubMed ID: 6169430
    [No Abstract]   [Full Text] [Related]  

  • 49. Skin bioassays in tobacco carcinogenesis.
    Hoffmann D; Wynder EL; Rivenson A; LaVoie EJ; Hecht SS
    Prog Exp Tumor Res; 1983; 26():43-67. PubMed ID: 6844647
    [No Abstract]   [Full Text] [Related]  

  • 50. Structure-activity relationships in chick embryo fibroblasts for phorbol-related diterpene esters showing anomalous activities in vivo.
    Driedger PE; Blumberg PM
    Cancer Res; 1980 Feb; 40(2):339-46. PubMed ID: 7356517
    [No Abstract]   [Full Text] [Related]  

  • 51. Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
    De Young LM; Helmes CT; Chao WR; Young JM; Miller V
    Cancer Res; 1981 Jan; 41(1):204-8. PubMed ID: 7448761
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition by a peri-fluorine atom of 1,2-dihydrodiol formation as a basis for the lower tumorigenicity of 12-fluoro-5-methylchrysene than of 5-methylchrysene.
    Amin S; Camanzo J; Hecht SS
    Cancer Res; 1984 Sep; 44(9):3772-8. PubMed ID: 6547637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1-Methylphenanthrene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():405-9. PubMed ID: 6586675
    [No Abstract]   [Full Text] [Related]  

  • 54. Decrease of epidermal histidase activity by tumor-promoting phorbol esters.
    Colburn NH; Lau S; Head R
    Cancer Res; 1975 Nov; 35(11 Pt 1):3154-9. PubMed ID: 1182705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
    Yasukawa K; Iida T; Fujimoto Y
    J Pharm Pharmacol; 2009 Aug; 61(8):1051-6. PubMed ID: 19703349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Skin carcinogenesis induced be neonatal administration of 5-bromo-2'-deoxyuridine and subsequent treatment with 12-O-tetradecanoylphorbol-13-acetate in mice].
    Anisimov VN; Sheiko EV
    Vopr Onkol; 1996; 42(1):82-4. PubMed ID: 8686251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Satyamoorthy K; Perchellet JP
    Cancer Res; 1989 Oct; 49(19):5364-70. PubMed ID: 2475247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutagenicity of benzo(e)pyrene and triphenylene tetrahydroepoxides and diol-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Huang MT; Levin W; Lehr RE; Kumar S; Thakker DR; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Jun; 40(6):1985-9. PubMed ID: 6989494
    [No Abstract]   [Full Text] [Related]  

  • 59. Carcinogenicity of 6-aminochrysene in mice.
    Lambelin G; Roba J; Roncucci R; Parmentier R
    Eur J Cancer (1965); 1975 May; 11(5):327-34. PubMed ID: 1171763
    [No Abstract]   [Full Text] [Related]  

  • 60. Carcinogenic metabolites of 5-methylchrysene.
    Pataki J; Lee H; Harvey RG
    Carcinogenesis; 1983; 4(4):399-402. PubMed ID: 6839413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.